Literature DB >> 13745741

Metabolic effects of glucagon in human subjects.

J M SALTER, C EZRIN, J C LAIDLAW, A G GORNALL.   

Abstract

Entities:  

Keywords:  GLUCAGON/pharmacology; TISSUE METABOLISM/pharmacology

Mesh：

Substances：

Year:  1960        PMID： 13745741

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  14 in total

1.  THE EFFECT OF GLUCAGON ON NET SPANCHNIC BALANCES OF GLUCOSE, AMINO ACID NITROGEN, UREA, KETONES, ANS OXYGEN IN MAN.

Authors:  R F KIBLER; W J TAYLOR; J D MYERS
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  Conversion of DL-lactate-2-C14 or -3-C14 or pyruvate-2-C14 to blood glucose in humans: effects of diabetes, insulin, tolbutamide, and glucose load.

Authors:  R C DE MEUTTER; W W SHREEVE
Journal:  J Clin Invest       Date:  1963-04       Impact factor: 14.808

3.  The contribution of endogenous insulin secretion to the ketogenic response to glucagon in man.

Authors:  D S Schade; R P Eaton
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

Review 4.  The metabolic actions of glucagon revisited.

Authors:  Kirk M Habegger; Kristy M Heppner; Nori Geary; Timothy J Bartness; Richard DiMarchi; Matthias H Tschöp
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

5.  Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.

Authors:  J E Gerich; M Lorenzi; D M Bier; E Tsalikian; V Schneider; J H Karam; P H Forsham
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

6.  Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men.

Authors:  J E Liljenquist; J D Bomboy; S B Lewis; B C Sinclair-Smith; P W Felts; W W Lacy; O B Crofford; G W Liddle
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

7.  Glucagon levels and metabolic effects in fasting man.

Authors:  E B Marliss; T T Aoki; R H Unger; J S Soeldner; G F Cahill
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

8.  Metabolic intervention in surgical patients. An assessment of the effect of somatostatin, ranitidine, naloxone, diclophenac, dipyridamole, or salbutamol infusion on energy and protein kinetics in surgical patients using stable and radioisotopes.

Authors:  J H Shaw; R R Wolfe
Journal:  Ann Surg       Date:  1988-03       Impact factor: 12.969

9.  Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.

Authors:  E Lien; D Sarantakis
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

10.  Glucagon's Metabolic Action in Health and Disease.

Authors:  Anja Zeigerer; Revathi Sekar; Maximilian Kleinert; Shelly Nason; Kirk M Habegger; Timo D Müller
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.